04:58 PM EDT, 06/05/2026 (MT Newswires) -- Unicycive Therapeutics ( UNCY ) said late Friday it has increased the number of shares that may be sold in an "at-the-market" offering with Guggenheim Securities to $150 million.

Its previous sales agreement was to sell shares of up to $100 million from time to time through the ATM offering, according to its regulatory filing. The firm said it has filed a shelf registration statement for the offering.